NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
摘要:
Novel p62 ligand compounds, or a stereoisomer, a solvate, a hydrate, or a prodrug thereof are disclosed. The novel compounds, stereoisomer, solvate, hydrate, or prodrug activates selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body, and thus can be advantageously used as a pharmaceutical composition for preventing, ameliorating, or treating various proteinopathies. Compositions such as pharmaceutical composition or food compositions containing the novel p62 ligand compounds, stereoisomer, solvate, hydrate, or prodrug thereof as well as uses thereof are disclosed.
NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES
摘要:
Novel p62 ligand compounds, or a stereoisomer, a solvate, a hydrate, or a prodrug thereof are disclosed. The novel compounds, stereoisomer, solvate, hydrate, or prodrug activates selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body, and thus can be advantageously used as a pharmaceutical composition for preventing, ameliorating, or treating various proteinopathies. Compositions such as pharmaceutical composition or food compositions containing the novel p62 ligand compounds, stereoisomer, solvate, hydrate, or prodrug thereof as well as uses thereof are disclosed.
ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180110873A1
公开(公告)日:2018-04-26
A compound capable of inhibiting cell proliferation, having a structure according to formula (I)
wherein the variables in formula (I) are as defined in the specification. Such compounds are useful as anti-cancer agents, especially in antibody-drug conjugates.
Metal- and base-free synthesis of imidazo[1,2-<i>a</i>]pyridines through elemental sulfur-initiated oxidative annulation of 2-aminopyridines and aldehydes
作者:Jing Tan、Penghui Ni、Huawen Huang、Guo-Jun Deng
DOI:10.1039/c8ob00981c
日期:——
The elemental sulfur-promoted oxidative cyclization reaction for the efficient synthesis of substituted imidazo[1,2-a]pyridines has been developed. Easily available 2-aminopyridines and aldehydes were directly assembled in a highly atom-economical fashion through oxidative annulation under metal- and base-free conditions. Besides arylacetaldehydes, aliphatic aldehydes were also compatible with this
已经开发出用于有效合成取代的咪唑并[1,2- a ]吡啶的元素硫促进的氧化环化反应。容易获得的2-氨基吡啶和醛类在无金属和无碱条件下通过氧化环化法以高度原子经济的方式直接组装。除芳基乙醛外,脂族醛也与该体系相容,以具有克级合成能力的优异收率递送烷基取代的咪唑并[1,2- a ]吡啶。
Novel N-formyl hydroxylamine compounds, compositions and methods of use
申请人:——
公开号:US20030045479A1
公开(公告)日:2003-03-06
N-[1-oxo-2-alkyl-3-(N-hydroxyformamido)-propyl]-(carbonylamino-aryl or -heteroaryl)-azacyclo
4-7
alkanes or thiazacyclo
4-7
alkanes or imidazacyclo
4-7
alkanes have interesting properties, e.g., in the treatment or prevention of disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections.
AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
申请人:Bahmanyar Sogole
公开号:US20100093698A1
公开(公告)日:2010-04-15
Provided herein are Heteroaryl Compounds of formula (I):
wherein R
1
and R
2
are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing inflammatory conditions or cancer, and conditions treatable or preventable by inhibition of a kinase or a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a subject in need thereof.
[EN] N-FORMYL HYDROXYLAMINE COMPOUNDS AS INHIBITORS OF PDF<br/>[FR] COMPOSES DE N-FORMYLE HYDROXYLAMINE EN TANT QU'INHIBITEURS DE PEPTIDYLE DEFORMYLASE (PDF)
申请人:VERSICOR INC
公开号:WO2002102790A1
公开(公告)日:2002-12-27
n-[01-oxo-2-alkyl-3-(N-hydroxyformamido)-propyl]-(carbonylamino-aryl or heteroaryl)- azacyclo 4-7 alkanes or thiazacyclo 4-7 alkanes or imidazacyclo 4-7 alkanes have interesting properties, e.g. in the treatment or prevention of disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections.